Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.6550 (-3.46%) ($8.6550 - $8.6550) on Mon. Jul. 24, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.81% (three month average) | RSI | 62 | Latest Price | $8.6550(-3.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.1% a day on average for past five trading days. | Weekly Trend | EDIT advances 1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(67%) ARKG(64%) IBB(57%) IWC(50%) ARKK(48%) | Factors Impacting EDIT price | EDIT will decline at least -2.405% in a week (0% probabilities). TBT(-24%) UUP(-15%) VXX(-5%) VIXM(-4%) EDOC(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.405% (StdDev 4.81%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.78(-1.42%) | 10 Day Moving Average | $8.82(-1.87%) | 20 Day Moving Average | $8.58(0.87%) | To recent high | -24.7% | To recent low | 12.4% | Market Cap | $538m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |